Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between radioactive iodine treatment for hyperthyroidism and cancer incidence and mortality.

The Journal of clinical endocrinology and metabolism·2026
Same author

Association between over- and under-replacement with thyroid hormone and incident heart failure.

The Journal of clinical endocrinology and metabolism·2025
Same author

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association·2025
Same author

Examining Why Thyroid Cancer Incidence Is High in Women.

Thyroid : official journal of the American Thyroid Association·2024
Same author

Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study.

Thyroid : official journal of the American Thyroid Association·2024
Same author

Social Determinants of Health and Disparities in Thyroid Care.

The Journal of clinical endocrinology and metabolism·2023
Same journal

Is diagnosis of Cushing's disease moving beyond Bilateral inferior petrosal sinus sampling?

The Journal of clinical endocrinology and metabolism·2026
Same journal

Can Machine Learning Transform the Diagnostic Approach to Congenital Disorders of Adrenal Steroidogenesis?

The Journal of clinical endocrinology and metabolism·2026
Same journal

Children's neurodevelopment at school age after hysterosalpingography with iodinated contrast: a cohort study.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Bone phenotype of patients with genetic forms of lipodystrophy: a systematic review of literature.

The Journal of clinical endocrinology and metabolism·2026
Same journal

The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Pathophysiology-Based Classification of Male Infertility: Evidence from an 800-patient Prospective Cohort.

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Approach to the Patient with Low-Risk Thyroid Cancer.

Susan Pitt1, Megan R Haymart2

  • 1Division of Endocrine Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, United States.

The Journal of Clinical Endocrinology and Metabolism
|June 24, 2026
PubMed
Summary
This summary is machine-generated.

The 2025 American Thyroid Association guidelines offer updated management for differentiated thyroid cancer. They emphasize shared decision-making and de-escalating care for low-risk patients, focusing on survivorship.

Keywords:
cancer survivorshiplow-risk cancershared decision makingthyroid cancerthyroid surgery

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Related Experiment Videos

Last Updated: Jun 25, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Area of Science:

  • Endocrinology
  • Oncology
  • Clinical Practice Guidelines

Background:

  • Differentiated thyroid cancer (DTC) management evolves with new evidence.
  • Most DTC patients present with low-risk disease.
  • Updated guidelines are crucial for optimal patient care.

Purpose of the Study:

  • To summarize the 2025 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.
  • To highlight key recommendations for low-risk DTC patients.
  • To illustrate management strategies through clinical cases.

Main Methods:

  • Review of the latest evidence in differentiated thyroid cancer management.
  • Development of clinical recommendations by the ATA.
  • Presentation of illustrative case studies for low-risk DTC.

Main Results:

  • The 2025 ATA guidelines provide updated recommendations for low to high-risk DTC.
  • Emphasis on shared decision-making for low-risk patients.
  • Focus on de-escalating care and long-term survivorship for recurrence-free patients.

Conclusions:

  • The 2025 ATA guidelines promote personalized and de-escalated care for low-risk DTC.
  • Shared decision-making is central to managing differentiated thyroid cancer.
  • Long-term survivorship care is a key component for DTC patients.